Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma

Guidelines from the American Society for Blood and Marrow Transplantation

Miguel Angel Perales, Izaskun Ceberio, Philippe Armand, Linda J. Burns, Robert Chen, Peter D. Cole, Andrew M. Evens, Ginna G. Laport, Craig H. Moskowitz, Uday Popat, Nishitha M. Reddy, Thomas C. Shea, Julie M. Vose, Jeffrey Schriber, Bipin N. Savani, Paul A. Carpenter

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The role of hematopoietic cell transplantation (HCT) in the therapy of Hodgkin lymphoma (HL) in pediatric and adult patients is reviewed and critically evaluated in this systematic evidence-based review. Specific criteria were used for searching the published literature and for grading the quality and strength of the evidence and the strength of the treatment recommendations. Treatment recommendations based on the evidence are included and were reached unanimously by a panel of HL experts. Both autologous and allogeneic HCT offer a survival benefit in selected patients with advanced or relapsed HL and are currently part of standard clinical care. Relapse remains a significant cause of failure after both transplant approaches, and strategies to decrease the risk of relapse remain an important area of investigation.

Original languageEnglish (US)
Pages (from-to)971-983
Number of pages13
JournalBiology of Blood and Marrow Transplantation
Volume21
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Cell Transplantation
Hodgkin Disease
Transplantation
Bone Marrow
Guidelines
Recurrence
Standard of Care
Therapeutics
Pediatrics
Transplants
Survival

Keywords

  • Allogeneic transplant
  • Autologous transplant
  • Hematopoietic cell transplantation
  • Hodgkin lymphoma

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Cite this

Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma : Guidelines from the American Society for Blood and Marrow Transplantation. / Perales, Miguel Angel; Ceberio, Izaskun; Armand, Philippe; Burns, Linda J.; Chen, Robert; Cole, Peter D.; Evens, Andrew M.; Laport, Ginna G.; Moskowitz, Craig H.; Popat, Uday; Reddy, Nishitha M.; Shea, Thomas C.; Vose, Julie M.; Schriber, Jeffrey; Savani, Bipin N.; Carpenter, Paul A.

In: Biology of Blood and Marrow Transplantation, Vol. 21, No. 6, 01.06.2015, p. 971-983.

Research output: Contribution to journalArticle

Perales, MA, Ceberio, I, Armand, P, Burns, LJ, Chen, R, Cole, PD, Evens, AM, Laport, GG, Moskowitz, CH, Popat, U, Reddy, NM, Shea, TC, Vose, JM, Schriber, J, Savani, BN & Carpenter, PA 2015, 'Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma: Guidelines from the American Society for Blood and Marrow Transplantation', Biology of Blood and Marrow Transplantation, vol. 21, no. 6, pp. 971-983. https://doi.org/10.1016/j.bbmt.2015.02.022
Perales, Miguel Angel ; Ceberio, Izaskun ; Armand, Philippe ; Burns, Linda J. ; Chen, Robert ; Cole, Peter D. ; Evens, Andrew M. ; Laport, Ginna G. ; Moskowitz, Craig H. ; Popat, Uday ; Reddy, Nishitha M. ; Shea, Thomas C. ; Vose, Julie M. ; Schriber, Jeffrey ; Savani, Bipin N. ; Carpenter, Paul A. / Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma : Guidelines from the American Society for Blood and Marrow Transplantation. In: Biology of Blood and Marrow Transplantation. 2015 ; Vol. 21, No. 6. pp. 971-983.
@article{773e84f6876a4a4983b8c566dce0ff0f,
title = "Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma: Guidelines from the American Society for Blood and Marrow Transplantation",
abstract = "The role of hematopoietic cell transplantation (HCT) in the therapy of Hodgkin lymphoma (HL) in pediatric and adult patients is reviewed and critically evaluated in this systematic evidence-based review. Specific criteria were used for searching the published literature and for grading the quality and strength of the evidence and the strength of the treatment recommendations. Treatment recommendations based on the evidence are included and were reached unanimously by a panel of HL experts. Both autologous and allogeneic HCT offer a survival benefit in selected patients with advanced or relapsed HL and are currently part of standard clinical care. Relapse remains a significant cause of failure after both transplant approaches, and strategies to decrease the risk of relapse remain an important area of investigation.",
keywords = "Allogeneic transplant, Autologous transplant, Hematopoietic cell transplantation, Hodgkin lymphoma",
author = "Perales, {Miguel Angel} and Izaskun Ceberio and Philippe Armand and Burns, {Linda J.} and Robert Chen and Cole, {Peter D.} and Evens, {Andrew M.} and Laport, {Ginna G.} and Moskowitz, {Craig H.} and Uday Popat and Reddy, {Nishitha M.} and Shea, {Thomas C.} and Vose, {Julie M.} and Jeffrey Schriber and Savani, {Bipin N.} and Carpenter, {Paul A.}",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.bbmt.2015.02.022",
language = "English (US)",
volume = "21",
pages = "971--983",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma

T2 - Guidelines from the American Society for Blood and Marrow Transplantation

AU - Perales, Miguel Angel

AU - Ceberio, Izaskun

AU - Armand, Philippe

AU - Burns, Linda J.

AU - Chen, Robert

AU - Cole, Peter D.

AU - Evens, Andrew M.

AU - Laport, Ginna G.

AU - Moskowitz, Craig H.

AU - Popat, Uday

AU - Reddy, Nishitha M.

AU - Shea, Thomas C.

AU - Vose, Julie M.

AU - Schriber, Jeffrey

AU - Savani, Bipin N.

AU - Carpenter, Paul A.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - The role of hematopoietic cell transplantation (HCT) in the therapy of Hodgkin lymphoma (HL) in pediatric and adult patients is reviewed and critically evaluated in this systematic evidence-based review. Specific criteria were used for searching the published literature and for grading the quality and strength of the evidence and the strength of the treatment recommendations. Treatment recommendations based on the evidence are included and were reached unanimously by a panel of HL experts. Both autologous and allogeneic HCT offer a survival benefit in selected patients with advanced or relapsed HL and are currently part of standard clinical care. Relapse remains a significant cause of failure after both transplant approaches, and strategies to decrease the risk of relapse remain an important area of investigation.

AB - The role of hematopoietic cell transplantation (HCT) in the therapy of Hodgkin lymphoma (HL) in pediatric and adult patients is reviewed and critically evaluated in this systematic evidence-based review. Specific criteria were used for searching the published literature and for grading the quality and strength of the evidence and the strength of the treatment recommendations. Treatment recommendations based on the evidence are included and were reached unanimously by a panel of HL experts. Both autologous and allogeneic HCT offer a survival benefit in selected patients with advanced or relapsed HL and are currently part of standard clinical care. Relapse remains a significant cause of failure after both transplant approaches, and strategies to decrease the risk of relapse remain an important area of investigation.

KW - Allogeneic transplant

KW - Autologous transplant

KW - Hematopoietic cell transplantation

KW - Hodgkin lymphoma

UR - http://www.scopus.com/inward/record.url?scp=84941214656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941214656&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2015.02.022

DO - 10.1016/j.bbmt.2015.02.022

M3 - Article

VL - 21

SP - 971

EP - 983

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 6

ER -